DSG2 and non-melanoma skin carcinoma: Flemming et al. discovered that Desmoglein 2 (Dsg2), a protein component of desmosomes, was highly expressed in non-melanoma skin cancers and regulated EV biogenesis and secretion from virtually every cell type, including keratinocytes, fibroblasts, and lymphocytes.